About Michael Parnell
Form D filings for O'Ryan Therapeutics in 2023 list Michael Parnell as president and CEO, director.
Michael Parnell first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Parnell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Parnell works with at each company, as listed on that company's latest Form D.
O'Ryan Therapeutics, Inc. · Form D, Sep 8, 2023
TC
Tim Coleman
Executive officer and director